Francis S. Collins

As a scientist and physician, I believe genetic engineering has immense potential for treating disease, but it must be approached with caution and robust ethical considerations. Genomic editing techniques, like CRISPR, could revolutionize our approach to incurable genetic disorders. Nonetheless, it's crucial to ensure that the application of such technologies adheres strictly to ethical guidelines to prevent misuse or unintended consequences.

As a geneticist and the Director of the National Institutes of Health, I recognize the potential of AI in the medical field. However, I believe we must proceed with caution. While AI can assist in diagnostics and treatment planning, the final decision should always involve human oversight to ensure patient safety and trust.